ICL Israel Chemicals Ltd (United States) is listed on the Nasdaq and has a market capitalization of $6.82 billion, with shareholders equity totaling $6.33 billion.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, ICL Israel Chemicals Ltd reported $7.41 billion in revenue, generating net income of $261.00 million.
Key financial metrics include a P/E ratio of 26.12, a price-to-book (P/B) ratio of 1.08, and a trailing twelve-month dividend yield of 3.36%.
The company trades under the ticker ICL.